STERIS plc (STE) stock
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/300% above fair value
$257.41−4.50 (-1.72%)
Close on Nov 17, 2026Market cap $25.10BP/E 31.5Yield 0.96%
Steris operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Steris's operating income for the twelve months ending Jun 30, 2026 was $1.14B, up 23.1% year over year. For fiscal 2026 it was $1.10B, up 27.1% from the year before. The highest annual figure on record is $1.10B in fiscal 2026.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $1.10B | +27.1% |
| FY2025 | Mar 31, 2025 | $866.60M | +3.6% |
| FY2024 | Mar 31, 2024 | $836.10M | +5.7% |
| FY2023 | Mar 31, 2023 | $791.10M | +65.6% |
| FY2022 | Mar 31, 2022 | $477.82M | -12.9% |
| FY2021 | Mar 31, 2021 | $548.37M | +2.1% |
| FY2020 | Mar 31, 2020 | $537.05M | +30.7% |
| FY2019 | Mar 31, 2019 | $411.02M | +2.8% |
| FY2018 | Mar 31, 2018 | $399.88M | +76.8% |
| FY2017 | Mar 31, 2017 | $226.21M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $285.80M | +16.2% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $316.80M | +46.6% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $273.20M | +11.4% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $265.80M | +21.0% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $246.00M | +32.6% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $216.10M | -1.9% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $245.30M | +8.3% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $219.70M | +14.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $185.50M | -6.2% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $220.32M | -70.6% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $226.47M | +18.7% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $191.55M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $197.76M | +24.9% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $748.32M | +419.5% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $190.80M | -6.0% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$306.42M | -363.0% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $158.40M | +1005.8% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $144.06M | -0.1% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $202.93M | +38.0% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $116.50M | -17.5% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $14.32M | -87.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $144.26M | -8.6% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $147.03M | +3.3% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $141.26M | +11.5% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $115.82M | +5.2% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $157.84M | +12.4% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $142.39M | +104.6% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $126.73M | +18.9% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $110.09M | +16.6% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $140.44M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $69.58M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $106.58M | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $94.42M | – |
See a number that looks wrong?